Gallbladder Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gallbladder Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels [Phase 2]
Phase 2 Yale-sponsored trial evaluating adding sequential cytoreductive intervention to standard-of-care therapy for metastatic foregut aden…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels [Phase 2]
Phase 2 study evaluating chemotherapy with or without sequential cytoreductive surgery for metastatic foregut cancer with undetectable circu…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma [Phase 1]
Phase 1 trial evaluating PEGPH20 with cisplatin and gemcitabine, with or without atezolizumab, in previously untreated unresectable/metastat…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer [Phase 2]
This clinical trial update reports the results of a Phase 2 study evaluating capecitabine, oxaliplatin, and bevacizumab with radiation thera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer [Phase 2]
A Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in biliary tract cancers (including gallbladder aden…